|
Report No. : |
332250 |
|
Report Date : |
23.07.2015 |
IDENTIFICATION DETAILS
|
Name : |
"GEMINI" INDÚSTRIA DE INSUMOS FARMACÊUTICOS LTDA |
|
|
|
|
Registered Office : |
Via Primária 4D - S/Nº, Quadra 8 -A - Módulos I E II - Daia |
|
|
|
|
Country : |
Brazil |
|
|
|
|
Financials (as on) : |
31.12.2014 |
|
|
|
|
Date of Incorporation : |
23.01.2009 |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacture, import and distribution of pharmaceutical products. |
|
|
|
|
No. of Employee : |
80 Employee(S) |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made on
e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2015
|
Country Name |
Previous Rating (31.12.2014) |
Current Rating (31.03.2015) |
|
Brazil |
B2 |
B2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
BRAZIL ECONOMIC OVERVIEW
Characterized by large and well-developed agricultural, mining, manufacturing, and service sectors, and a rapidly expanding middle class, Brazil's economy outweighs that of all other South American countries, and Brazil is expanding its presence in world markets. Since 2003, Brazil has steadily improved its macroeconomic stability, building up foreign reserves, and reducing its debt profile by shifting its debt burden toward real denominated and domestically held instruments. Since 2008, Brazil became a net external creditor and all three of the major ratings agencies awarded investment grade status to its debt. After strong growth in 2007 and 2008, the onset of the global financial crisis hit Brazil in 2008. Brazil experienced two quarters of recession, as global demand for Brazil's commodity-based exports dwindled and external credit dried up. However, Brazil was one of the first emerging markets to begin a recovery. In 2010, consumer and investor confidence revived and GDP growth reached 7.5%, the highest growth rate in the past 25 years. After reaching historic lows of 4.5% in early 2014, the unemployment rate remains low, but is rising. Brazil's traditionally high level of income inequality has declined for each of the last 15 years. GDP growth has slowed since 2011, due to several factors, including: overdependence on exports of raw commodities, low productivity, high operational costs, persistently high inflation, and low levels of investment. Brazil’s fiscal and current account balances have eroded during the past four years as the government attempted to boost economic growth through targeted tax cuts for industry and incentives to spur household consumption. After winning re-election in October 2014 by a historically narrow margin, President Dilma ROUSSEFF appointed a new economic team led by Finance Minister Joaquim LEVY, who introduced a fiscal austerity package intended to restore the primary account surplus to 1.2% of GDP and preserve the country’s investment-grade sovereign credit rating. Brazil seeks to strengthen its workforce and its economy over the long run by imposing local content and technology transfer requirements on foreign businesses, by investing in education through social programs such as Bolsa Familia and the Brazil Science Mobility Program, and by investing in research in the areas of space, nanotechnology, healthcare, and energy.
|
Source
: CIA |
"GEMINI"
INDÚSTRIA DE INSUMOS FARMACÊUTICOS LTDA
ADDRESSES
|
|
MAIN ADDRESS: |
VIA PRIMÁRIA 4D - S/Nº, QUADRA 8 -A - MÓDULOS I E II - DAIA |
|
ZIP CODE/CITY: |
75133-590 - ANÁPOLIS/GO |
|
|
|
|
PHONE: |
62 4014-9100 |
|
FAX: |
62 4014-9102 |
|
E-MAIL: |
|
BRANCHES: |
|
|
|
|
|
ADDRESS: |
RUA FAUSTINO NEGRI,285 GALPÃO 05 - COOPERATIVA |
|
ZIP CODE/CITY: |
09851-720 SÃO BERNARDO DO CAMPO/SP |
|
CNPJ: |
10.690.195/0002-83 |
|
|
|
|
ADDRESS: |
RUA CORONEL CABRITA,137 - JARDIM DA GLÓRIA |
|
ZIP CODE/CITY: |
01545-030 SÃO PAULO/SP |
LEGAL
DATA
|
|
MAIN ACTIVITIES: |
|
MANUFACTURE, IMPORT AND DISTRIBUTION OF PHARMACEUTICAL PRODUCTS. |
|
LEGAL FORM: |
LIMITED
LIABILITY COMPANY |
|
|
|
|
INCORPORATION DATE: |
23/01/2009 |
|
REGISTER DATE: |
12/03/2009 |
|
BALANCE SHEET FILING DATE: |
31/12 |
|
TAX CONTRIBUTOR NUMBER(CNPJ): |
10.690.195/0001-00 |
|
STATE REGISTER: |
10.450.596-6 |
|
|
|
|
SHARE CAPITAL: |
R$ 10.000.000,00 |
|
BOARD OF
DIRECTORS: |
|
|
|
|
|
JÚLIO TOMIZO TANAKA |
MANAGING PARTNER |
|
VALDETE VIODRES TANAKA |
MANAGING PARTNER |
AUTHORIZED
USE OF SIGNATURE
|
|
THE MANAGING PARTNERS ARE AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY. |
|
SHAREHOLDERS /
PARTNERS: |
|
|
|
|
|
JÚLIO TOMIZO TANAKA |
50% |
|
VALDETE VIODRES TANAKA |
50% |
|
AFFILIATES /
SUBSIDIARIES: |
|
|
A SCAN THROUGH
OUTSIDE SOURCES SHOWED THE SUBJECT AND/OR DIRECTORS HAS/HAVE THE FOLLOWING
UNCONFIRMED HOLDINGS: |
|
|
LEVIALE - INDÚSTRIA COSMÉTICA LTDA |
|
|
GENIX - INDÚSTRIA FARMACÊUTICA LTDA |
|
|
PURIFARMA DISTRIBUIDORA QUÍMICA E FARMACÊUTICA LTDA |
|
|
BISNAGO INDÚSTRIA DE EMBALAGENS LTDA |
|
|
J. V. T. - CONSTRUTORA E INCORPORADORA LTDA. |
|
|
LVA PARTICIPAÇÕES LTDA. |
|
|
FARMACEUTICAL COML. IMPORTAÇÃO E EXPORTAÇÃO LTDA |
|
|
LEVIALE COMERCIAL DE COSMÉTICOS LTDA |
|
COMPANY'S
BACKGROUND
|
|
THE SUBJECT WAS ESTABLISHED ON JANUARY 23, 2009 TO BE ENGAGED IN THE
SAID LINE OF BUSINESS AND UP TO DATE IT IS STILL OPERATING WITHIN THE GENERAL
SCENE REPORTED HEREIN. THE COMPANY OPERATES WITH THE TRADE NAME "PURIFARMA". PARTNERS: JÚLIO TOMIZO TANAKA, BRAZILIAN, MARRIED, HOLDER OF DOCUMENTS, RG
11.005.913 SSP/SP AND CPF 006.297.068-24, RESIDENTIAL ADDRESS AT RUA ALAMEDA
DAS PRIMAVERAS 255, CONDOMINIO BOUGUEVILLE II - PERUÍBE/SP. VALDETE VIODRES TANAKA, BRAZILIAN, MARRIED, HOLDER OF DOCUMENTS, RG
15.652.513 SSP/SP AND CPF 075.619.338-94, RESIDENTIAL ADDRESS AT RUA ALAMEDA
DAS PRIMAVERAS 255, CONDOMINIO BOUGUEVILLE II - PERUÍBE/SP. FURTHER DETAILS ARE SO FAR NOT KNOWN. |
|
PUBLIC
INFORMATION: |
|
NO DETRIMENTAL FILES WERE FOUND. |
FINANCIAL
INFORMATION
|
|
GENERAL BALANCE SHEETS AS OF 31/12/2014, 31/12/2013 AND 31/12/2012. |
|
( FIGURES ARE IN REAIS ). |
|
ASSETS |
|
|
|
|
CURRENT: |
31/12/2014 |
31/12/2013 |
31/12/2012 |
|
|
|
|
|
|
CASH |
2.526,67 |
541,71 |
3.086,51 |
|
BANKS |
398.833,88 |
43.785,50 |
703.301,11 |
|
ADVANCES |
210.269,54 |
117.753,12 |
727.571,74 |
|
CLIENTS |
4.890.189,55 |
8.071.955,02 |
8.685.491,13 |
|
RECOVERABLE TAXES |
1.263.635,22 |
738.651,82 |
656.235,86 |
|
INVENTORY |
12.030.208,15 |
7.908.195,59 |
11.555.964,04 |
|
INVESTMENTS |
154.636,99 |
413.260,25 |
|
|
PRE PAID EXPENSES |
35.860,27 |
30.650,68 |
|
|
CHECKS |
7.295,09 |
|
|
|
OTHER |
96.927,67 |
|
|
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL CURRENT ASSETS |
19.090.383,03 |
17.324.793,69 |
22.331.650,39 |
|
LONG-TERM
RECEIVABLES: |
|
|
|
|
|
|
|
|
|
ACCOUNTS RECEIVABLES |
8.960.000,00 |
7.979.800,00 |
|
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL LONG-TERM RECEIVABLES |
8.960.000,00 |
7.979.800,00 |
|
|
FIXED ASSETS: |
|
|
|
|
|
|
|
|
|
FIXED ASSETS |
3.554.769,97 |
3.281.862,25 |
2.347.574,64 |
|
DEFERRED |
128.182,61 |
150.803,09 |
173.423,55 |
|
INTANGIBLE |
37.555,66 |
53.036,00 |
|
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL FIXED ASSETS |
3.720.508,24 |
3.485.701,34 |
2.520.998,19 |
|
|
================ |
================ |
================ |
|
TOTAL ASSETS |
31.770.891,27 |
28.790.295,03 |
24.852.648,58 |
|
LIABILITIES: |
|
|
|
|
CURRENT: |
31/12/2014 |
31/12/2013 |
31/12/2012 |
|
|
|
|
|
|
SALARIES PAYABLE |
144.070,49 |
148.058,32 |
71.639,86 |
|
SOCIAL OBLIGATIONS |
461.294,97 |
156.878,52 |
58.128,34 |
|
PROVISIONS |
|
303.368,88 |
130.546,70 |
|
TAXES & CONTRIBUTIONS |
767.485,70 |
2.179.812,91 |
1.071.039,04 |
|
ACCOUNTS PAYABLE |
307.903,80 |
276.488,49 |
259.546,69 |
|
SUPPLIERS |
8.213.802,78 |
7.015.472,64 |
7.009.508,16 |
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL CURRENT LIABILITIES |
9.894.557,74 |
10.080.079,76 |
8.600.408,79 |
|
LONG TERM
LIABILITIES: |
|
|
|
|
|
|
|
|
|
LOANS AND FINANCING |
7.522.574,13 |
4.693.075,09 |
6.115.888,94 |
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL LONG TERM LIABILITIES |
7.522.574,13 |
4.693.075,09 |
6.115.888,94 |
|
NET EQUITY: |
|
|
|
|
|
|
|
|
|
SHARE CAPITAL |
10.000.000,00 |
10.000.000,00 |
3.000.000,00 |
|
ACCRUED PROFIT (LOSS) |
845.420,61 |
508.801,39 |
7.136.350,85 |
|
CAPITAL RESERVES |
3.508.338,79 |
3.508.338,79 |
|
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL NET EQUITY |
14.353.759,40 |
14.017.140,18 |
10.136.350,85 |
|
|
================ |
================ |
================ |
|
TOTAL LIABILITIES |
31.770.891,27 |
28.790.295,03 |
24.852.648,58 |
|
PROFIT AND LOSS ACCOUNTS AS OF 31/12/2014, 31/12/2013 AND 31/12/2012. |
|
( FIGURES ARE IN REAIS ). |
|
|
31/12/2014 |
31/12/2013 |
31/12/2012 |
|
|
|
|
|
|
GROSS SALES |
52.921.499,64 |
72.095.401,16 |
50.895.510,03 |
|
(-) TAXES ON SALES |
7.748.654,63 |
8.431.561,31 |
6.993.345,19 |
|
|
---------------- |
---------------- |
---------------- |
|
NET SALES |
45.172.845,01 |
63.663.839,85 |
43.902.164,84 |
|
(-) COST OF SOLD GOODS |
29.326.749,65 |
43.614.603,32 |
30.404.726,33 |
|
|
---------------- |
---------------- |
---------------- |
|
GROSS PROFIT |
15.846.095,36 |
20.049.236,53 |
13.497.438,51 |
|
OPERATING REVENUE (EXPENSE) |
-10.631.189,11 |
-7.483.755,17 |
-2.541.335,39 |
|
FINANCIAL REVENUE(EXPENSE) |
-1.100.053,67 |
2.546.133,08 |
-455.580,65 |
|
|
---------------- |
---------------- |
---------------- |
|
OPERATIONAL PROFIT (LOSS) |
4.114.852,58 |
15.111.614,44 |
10.500.522,47 |
|
CONTRIBUTION/INCOME TAX |
-1.658.028,32 |
-3.916.033,66 |
-1.613.972,31 |
|
|
---------------- |
---------------- |
---------------- |
|
NET PROFIT (LOSS) |
2.456.824,26 |
11.195.580,78 |
8.886.550,16 |
|
MONTHLY SALES |
|||
|
|
2015 |
2014 |
2013 |
|
|
--------------------- |
--------------------- |
--------------------- |
|
JANUARY |
R$ 4.397.346,37 |
R$ 4.882.396,83 |
R$ 5.823.254,49 |
|
FEBRUARY |
R$ 3.255.278,01 |
R$ 4.076.012,04 |
R$ 6.096.907,20 |
|
MARCH |
R$ 4.429.032,66 |
R$ 4.268.664,00 |
R$ 5.964.542,57 |
|
APRIL |
R$ 3.976.977,60 |
R$ 4.362.423,09 |
R$ 6.335.366,39 |
|
MAY |
R$ 4.427.976,37 |
R$ 5.183.617,43 |
R$ 5.752.045,86 |
|
JUNE |
R$ 4.599.249,05 |
R$ 3.454.227,15 |
R$ 5.738.756,84 |
|
JULY |
|
R$ 4.611.536,15 |
R$ 5.601.455,64 |
|
AUGUST |
|
R$ 4.756.385,60 |
R$ 6.692.927,97 |
|
SEPTEMBER |
|
R$ 4.920.242,21 |
R$ 9.229.270,69 |
|
OCTOBER |
|
R$ 4.509.327,99 |
R$ 5.573.205,49 |
|
NOVEMBER |
|
R$ 4.125.811,12 |
R$ 4.693.572,54 |
|
DECEMBER |
|
R$ 3.130.234,35 |
R$ 5.652.198,52 |
|
TOTAL |
R$ 25.085.860,06 |
R$ 52.280.877,96 |
R$ 73.153.504,20 |
|
RATIOS: |
31/12/2014 |
31/12/2013 |
31/12/2012 |
|
QUICK RATIO |
,71 |
|
,93 |
|
1,25 |
|
|
CURRENT RATIO |
1,93 |
|
1,72 |
|
2,60 |
|
|
ACCOUNTS RECEIVABLE TURNOVER |
9,24 |
TIMES |
7,89 |
TIMES |
5,05 |
TIMES |
|
DAYS' SALES IN RECEIVABLES |
38,97 |
DAYS |
45,64 |
DAYS |
71,22 |
DAYS |
|
INVENTORY TURNOVER |
2,44 |
TIMES |
5,52 |
TIMES |
2,63 |
TIMES |
|
ACCOUNTS PAYABLE PERIOD |
100,83 |
DAYS |
57,91 |
DAYS |
82,99 |
DAYS |
|
RETURN ON ASSETS |
1,42 |
TIMES |
2,21 |
TIMES |
1,77 |
TIMES |
|
SALES TURNOVER ON NET EQUITY |
3,15 |
TIMES |
4,54 |
TIMES |
4,33 |
TIMES |
|
NET WORTH TIE-UP |
,25 |
|
,23 |
|
,23 |
|
|
INDEBTEDNESS |
1,21 |
|
1,05 |
|
1,45 |
|
|
EQUITY RATIO |
45,18 |
% |
48,69 |
% |
40,79 |
% |
|
WORKING CAPITAL RATIO |
92,94 |
% |
71,87 |
% |
159,66 |
% |
|
GENERAL SOLVENCY |
1,82 |
|
1,95 |
|
1,69 |
|
|
RETURN ON NET EQUITY |
17,12 |
% |
79,87 |
% |
87,67 |
% |
|
RETURN ON SALES (PROFIT MARGIN) |
5,44 |
% |
17,59 |
% |
20,24 |
% |
|
GROSS PROFIT MARGIN |
35,08 |
% |
31,49 |
% |
30,74 |
% |
|
OPERATIONAL RESULT |
9,11 |
% |
23,74 |
% |
23,92 |
% |
|
SALES TURNOVER ON LIABILITIES |
4,57 |
TIMES |
6,32 |
TIMES |
5,10 |
TIMES |
|
FOREIGN CURRENCY ON ASSETS |
|
|
|
|
|
|
|
FOREIGN CURRENCY ON LIABILITIES |
|
|
|
|
|
|
|
EXCHANGE RATE: |
|
|
US$ 1,00 = R$ 3,21 |
- OFFICIAL RATE ON 21/07/2015 |
|
US$ 1,00 = R$ 2,65 |
- OFFICIAL RATE ON 31/12/2014 |
|
US$ 1,00 = R$ 2,34 |
- OFFICIAL RATE ON 31/12/2013 |
|
US$ 1,00 = R$ 2,04 |
- OFFICIAL RATE ON 31/12/2012 |
|
COMMENTS ON THE
FINANCIAL INFORMATION: |
|
FOLLOWS ATTACHED WORKSHEET WITH MAIN FINANCIAL RATIOS. THE FIGURES AVAILABLE SHOW A SATISFACTORY FINANCIAL STANDING. THE LEVEL
OF INDEBTEDNESS IS HIGH BUT IT IS NOTED GOOD CURRENT RATIO AND POSITIVE
WORKING CAPITAL AMOUNT. IN ADDITION IT SHOWS DROP IN SALES BUT POSTED
PROFITABILITY. REMARKS: THE COMPANY STARTED ITS OPERATIONS IN 2010 ONLY. |
|
REAL ESTATE: |
OWNED PREMISES ARE VALUED AT R$
890.781,51
|
VEHICLES: |
NOT AVAILABLE
|
MACHINES: |
NOT AVAILABLE
|
INSURANCE |
|
NOT AVAILABLE. |
BANKING
REFERENCES
|
|
|
BRANCH/PHONE: |
|
|
BANCO DO BRASIL S/A |
3388-X / 62 3311-1633 |
|
|
REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO PROVIDE
INFORMATION OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW
PROHIBITION WE ARE UNABLE TO PROVIDE ANY BANKING DETAILS. ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL REPORT, THE COMPANY
HAS NO RETURNED CHECKS UP TO DATE. (IN THE TERMS OF "CIRCULAR 1682
BRAZILIAN CENTRAL BANK"). DATE RESEARCHED JULY 21, 2015. |
ACTIVITIES
COMMENTS
|
|
MANUFACTURE, IMPORT AND DISTRIBUTION OF PHARMACEUTICAL PRODUCTS. |
|
IMPORT AND
EXPORT: |
IMPORTS FROM:
|
NOT AVAILABLE. |
EXPORTS TO:
|
NOT AVAILABLE. |
|
MAIN CLIENTS: |
|
|
|
|
|
|
|
DOMESTIC
CLIENTS: |
|
|
|
NOT AVAILABLE. |
|
|
|
STAFF: |
|
|
|
THE COMPANY HAS: 80 EMPLOYEE(S) |
CONCEPT
AND FULFILMENT
|
|
THE SUBJECT IS A NEWLY-ESTABLISHED COMPANY, OPERATING SINCE 2009. SO
FAR IT HAS A CLEAR TRADE HISTORY AND NORMAL PAYMENT BEHAVIOR. THE COMPANY HAS TRADE RELATIONS WITH SOME LOCAL SUPPLIERS BUT UP TO
DATE ONLY SMALL PAYMENTS WERE REPORTED AND THE SUBJECT IS NOT SAID TO BE USER
OF TRADE CREDIT FACILITIES. |
|
MAIN SUPPLIERS: |
|
|
|
|
|
|
|
DOMESTIC
SUPPLIERS: |
|
|
|
NOT AVAILABLE. |
|
|
|
PAYMENT HISTORY: |
|
7 SUPPLIERS REPORTED PAYMENTS: |
|
TOTAL AMOUNT: R$ 15.515,00 |
|
|
|
AMOUNT OF INVOICES PAID: 21 |
|
TOTAL OF PROMPT PAYMENTS: 100% |
|
HIGHEST INVOICE: R$ 1.799,00 |
|
HIGHEST CREDIT: R$ 1.799,00 |
FINAL
OPINION
|
|
BASED ON THE GENERAL INFORMATION AVAILABLE IT IS BELIEVED THAT GOOD TRADE
RELATIONS MAY BE ESTABLISHED. CREDIT FACILITIES MAY BE EXTENDED WITHIN TERMS
AND AMOUNTS ADEQUATE TO THE COMPANY'S FINANCIAL STRENGTH. |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.63.53 |
|
|
1 |
Rs.99.19 |
|
Euro |
1 |
Rs.69.60 |
INFORMATION DETAILS
|
Analysis Done by
: |
KAS |
|
|
|
|
Report Prepared
by : |
ANK |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.